Comparison of registered and published primary outcomes in randomized controlled trials of gastroenterology and hepatology

Scandinavian Journal of Gastroenterology

Volumn 48, Issue 12, 2013, Pages 1474-1483

  Li, Xiao Qian ^a   Yang, Ge Liang ^a   Tao, Kun Ming ^b   Zhang, Hui Qing ^a   Zhou, Qing Hui ^a   Ling, Chang Quan ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Gastroenterology; Primary outcomes; Randomized controlled trials; Trial registration

Indexed keywords

ARTICLE; COMPARATIVE STUDY; DATA EXTRACTION; GASTROENTEROLOGY; HUMAN; INTERNAL MEDICINE; MEDICAL LITERATURE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGISTRATION;

GASTROENTEROLOGY; OUTCOME ASSESSMENT (HEALTH CARE); PUBLICATION BIAS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REGISTRIES; RESEARCH DESIGN; RESEARCH REPORT;

EID: 84892188215     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2013.845909     Document Type: Article

References (39)

1. Dickersin K, Rennie D. Registering clinical trials. JAMA 2003;290:516-23
2. Sim I, Chan AW, Gülmezoglu AM, Evans T, Pang T. Clinical trial registration: Transparency is the watchword. Lancet 2006;367:1631-3
3. Zarin DA, Ide NC, Tse T, Harlan WR, West JC, Lindberg DA. Issues in the registration of clinical trials. JAMA 2007;297:2112-20
4. Yu H, Liu JP. A review of international clinical trial registration. J Chin Integr Med 2007;5:234-42
5. De Angelis CD, Drazen JM, Frizelle FA, Haug C, Hoey J, HortonR,etal.Isthisclinicaltrialfullyregistered? - Astatement from the International Committee ofMedical Journal Editors. N Engl JMed 2005;352:2436-8
6. Zarin DA, Tse T, Ide NC. Trial Registration at Clinical- Trials.gov between May and October 2005. N Engl J Med 2005;353:2779-87
7. Faure H, Hrynaszkiewicz I. The ISRCTN register: Achievements and challenges 8 years on. J Evid Based Med 2011;4: 188-92
8. Califf RM, Zarin DA, Kramer JM, Sherman RE, Aberle LH, Tasneem A. Characteristics of clinical trials registered in ClinicalTrials.gov, 2007-2010. JAMA 2012; 307:1838-47
9. van de Wetering FT, Scholten RJ, Haring T, Clarke M, Hooft L. Trial registration numbers are underreported in biomedical publications. PLoS One 2012;7:e49599
10. Food and Drug Administration Amendments Act of 2007. Available at http://www.fda.gov/downloads/NewsEvents/ Newsroom/MediaTranscripts/UCM123579. pdf.Accessed April 30, 2013
11. Laine C, Horton R, De Angelis C, Drazen JM, Frizelle FA, Godlee F, et al. Clinical trial registration. looking back and moving ahead. BMJ 2007;334:1177-8
12. Hirsch L. Trial registration and results disclosure: Impact of US legislation on sponsors, investigators, and medical journal editors. Curr Med Res Opin 2008;24:1683-9
13. Krleza-Jerić K, Lemmens T. 7th revision of the. Declaration of Helsinki: Good news for the transparency of clinical trials. Croat Med J 2009;50:105-10
14. Mathieu S, Boutron I, Moher D, Altman DG, Ravaud P. Comparison of registered and published primary outcomes in randomized controlled trials. JAMA 2009;302:977-84
15. Kunath F, Grobe HR, Keck B, Rücker G, Wullich B, Antes G, et al. Do urology journals enforce trial registration? A cross-sectional study of published trials. BMJ Open 2011; 1:e000430
16. You B, Gan HK, Pond G, Chen EX. Consistency in the analysis and reporting of primary end points in oncology randomized controlled trials from registration to publication: A systematic review. J Clin Oncol 2012;30:210-16
17. Jones CW, Platts-Mills TF. Quality of registration for clinical trials published in emergency medicine journals. Ann Emerg Med 2012;60:458-64
18. Hannink G, Gooszen HG, Rovers MM. Comparison of registered and published primary outcomes in randomized clinical trials of surgical interventions. Ann Surg 2013;257: 818-23
19. Bourgeois FT, Murthy S, Mandl KD. Outcome reporting among drug trials registered in ClinicalTrials.gov. Ann Intern Med 2010;153:158-66
20. Rasmussen N, Lee K, Bero L. Association of trial registration with the results and conclusions of published trials of new oncology drugs. Trials 2009;10:116
21. Stanley K. Design of randomized controlled trials. Circulation 2007;115:1164-9
22. Wyler von Ballmoos M, Oliveira C. The ClinicalTrials.gov results database - Update and key issues. N Engl J Med 2011;364:2169
23. Smith R. Medical journals are an extension of the marketing arm of pharmaceutical companies. PLoS Med 2005;2:e138
24. Chan AW, Hróbjartsson A, Haahr MT, Gøtzsche PC, Altman DG. Empirical evidence for selective reporting of outcomes in randomized trials: Comparison of protocols to published articles. JAMA 2004;291:2457-65
25. Dickersin K, Min YI. NIH clinical trials and publication bias. Online J Curr Clin Trials 1993; Doc No 50
26. Lexchin J, Bero LA, Djulbegovic B, Clark O. Pharmaceutical industry sponsorship and research outcome and quality: Systematic review. BMJ 2003;326:1167-70
27. Bero L, Oostvogel F, Bacchetti P, Lee K. Factors associated with findings of published trials of drug-drug comparisons: Why some statins appear more efficacious than others. PLoS Med 2007;4:e184
28. Olson CM, Rennie D, Cook D, Dickersin K, Flanagin A, Hogan JW, et al. Publication bias in editorial decision making. JAMA 2002;287:2825-8
29. Chan AW. Bias, spin, and misreporting: Time for full access to trial protocols and results. PLoS Med 2008;5:e230
30. Groves T. Mandatory disclosure of trial results for drugs and devices. BMJ 2008;336:170
31. Ridker PM, Torres J. Reported outcomes in major cardiovascular clinical trials funded by for-profit and not-for-profit organizations: 2000-2005. JAMA 2006;295:2270-4
32. Als-Nielsen B, Chen W, Gluud C, Kjaergard LL. Association of funding and conclusions in randomized drug trials: A reflection of treatment effect or adverse events? JAMA 2003;290:921-8
33. Sismondo S. How pharmaceutical industry funding affects trial outcomes: Causal structures and responses. Soc Sci Med 2008;66:1909-14
34. Roseman M, Milette K, Bero LA, Coyne JC, Lexchin J, Turner EH, et al. Reporting of conflicts of interest in meta-analyses of trials of pharmacological treatments. JAMA 2011; 305:1008-17
35. Golder S, Loke YK. Is there evidence for biased reporting of published adverse effects data in pharmaceutical industry-funded studies? Br J Clin Pharmacol 2008;66:767-73
36. Steinbrook R. Registration of clinical trials-voluntary or mandatory? N Engl J Med 2004;351:1820-2
37. Krleza-Jerić K. Clinical trial registration: The differing views of industry, the WHO, and the Ottawa Group. PLoS Med 2005;2:e378
38. Wu TX, Li YP, Liu GJ, Li J. Clinical trial registration system and evidence-based medicine. J Chin Integr Med 2007;5: 229-33
39. Cheng CW, Fu SF, Zhou QH, Wu TX, Shang HC, Tang XD, et al. Extending the CONSORT Statement to moxibustion. J Integr Med 2013;11:54-63